Thank you for subscribing!
Finfeed Archived Feb 08, 2021
Whilst the first visual point of call when observing a publicly traded company online is its share price and chart, perhaps the most indicative and telling value for any investor is the market capitalisation.
Finfeed Archived May 11, 2020
There has been continual strong news flow from the Genetic Signature Ltd (ASX: GSS), as it received CE-IVD registration for its SARS-CoV-2 Detection Kit, as well as notification from the Therapeutic Goods Administration (TGA) that its EasyScreenTM SARS-CoV-2 Detection Kit has been approved to be listed on the ARTG in Australia.
Finfeed Archived Mar 25, 2020
Should companies have been sold down so drastically, particularly given that for the best part their exploration and research activities were uninterrupted and they didn’t have a disrupted revenue/earnings stream.
Get expert stock analysis direct in your inbox
Join Our Mailing List